Top rated prostate cancer clinical trials in Boston, Massachusetts
Here are the top 10 medical studies for prostate cancer in Boston, Massachusetts
Popular filter options for prostate-cancer boston trials
Phase 3 Clinical Trials
View 100 phase 3 medical studies.
Hormone Therapy
Antiandrogen + Radiation +/- Docetaxel for Prostate Cancer
Recruiting1 awardPhase 2 & 3
Newark, Delaware
This trial is testing docetaxel in combination with antiandrogen therapy and radiation therapy versus antiandrogen therapy and radiation therapy alone in treating patients with prostate cancer that has been removed by surgery.
Cancer Vaccine
ProstAtak® Immunotherapy + Radiation for Prostate Cancer
Recruiting1 awardPhase 3
Worcester, Massachusetts
This trial is testing whether adding ProstAtak immunotherapy to radiation therapy can improve outcomes for patients with localized prostate cancer at high or intermediate risk for the disease coming back.
Hormone Therapy
Standard Therapy + Surgery/Radiation for Prostate Cancer
Recruiting2 awardsPhase 3
New Haven, Connecticut
This trial is testing whether adding surgery or radiation therapy to standard treatment for prostate cancer that has spread to other parts of the body lowers the chance of the cancer growing or spreading.
Clinical Trials With No Placebo
View 100 medical studies that do not have a placebo group.
Checkpoint Inhibitor
Nivolumab + Ipilimumab for Genitourinary Cancers
Recruiting1 awardPhase 2
Boston, Massachusetts
This trial is studying a combination of two drugs, Nivolumab and Ipilimumab, as a possible treatment for rare genitourinary cancers. Bladder and upper tract carcinomas with variant histology, adrenocortical carcinoma, other rare genitourinary carcinomas, and any genitourinary carcinoma with neuroendocrine differentiation are being studied. Given preliminary results, the study is being tested in additional patients with bladder or upper tract carcinoma with variant histology at this time.
Tyrosine Kinase Inhibitor
Cabozantinib + Atezolizumab for Advanced Cancers
Recruiting1 awardPhase 1 & 2
Boston, Massachusetts
This trial is testing the safety and effectiveness of a new cancer drug when used in combination with another cancer drug. The new drug is being tested on people with different types of cancer, including bladder, kidney, prostate, and breast cancer.
Hormone Therapy
Antiandrogen + Radiation +/- Docetaxel for Prostate Cancer
Recruiting1 awardPhase 2 & 3
Newark, Delaware
This trial is testing docetaxel in combination with antiandrogen therapy and radiation therapy versus antiandrogen therapy and radiation therapy alone in treating patients with prostate cancer that has been removed by surgery.
View More Prostate-cancer Boston Trials
See another 85 medical studies focused on prostate-cancer boston.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.